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ABSTRACT
In the hierarchy of data, information and knowledge,
computational methods play a major role in the initial
processing of data to extract information, but they
alone become less effective to compile knowledge
from information. The Kyoto Encyclopedia of Genes
and Genomes (KEGG) resource (http://www.kegg.
jp/ or http://www.genome.jp/kegg/) has been de-
veloped as a reference knowledge base to assist
this latter process. In particular, the KEGG
pathway maps are widely used for biological inter-
pretation of genome sequences and other high-
throughput data. The link from genomes to
pathways is made through the KEGG Orthology
system, a collection of manually defined ortholog
groups identified by K numbers. To better
automate this interpretation process the KEGG
modules defined by Boolean expressions of K
numbers have been expanded and improved. Once
genes in a genome are annotated with K numbers,
the KEGG modules can be computationally
evaluated revealing metabolic capacities and other
phenotypic features. The reaction modules, which
represent chemical units of reactions, have been
used to analyze design principles of metabolic
networks and also to improve the definition of
K numbers and associated annotations. For transla-
tional bioinformatics, the KEGG MEDICUS resource
has been developed by integrating drug labels
(package inserts) used in society.
INTRODUCTION
Bioinformatics has been a data-driven discipline. In the
era of high-throughput biology it enables extraction of
meaningful information from large amounts of data
generated by systematic experiments. Such information
may be of practical use, but it does not necessarily
represent biological knowledge. A more focused
approach in traditional biology, which is often hypoth-
esis-driven or model-driven, is necessary to analyze
low-throughput but high-quality data and to acquire
knowledge. For example, a disease-associated gene
identified by a genome-wide association study may be
just information, but a disease mechanism involving a per-
turbed signaling pathway uncovered by a more detailed
analysis may be called knowledge. In the hierarchy of
data, information and knowledge, computations with
elaborate algorithms play a major role in the initial pro-
cessing of data to information, but computations with
good reference databases become more important in the
following processing to compile knowledge.
In 1995, we started the Kyoto Encyclopedia of Genes
and Genomes (KEGG) database project foreseeing the
need for a reference resource that can be used for biolo-
gical interpretation of genome sequence data. In particu-
lar, we started developing a reference pathway database
by capturing and organizing experimental knowledge
from published literature, first focusing on metabolism
but soon followed by other cellular processes. The
KEGG resource has been expanded significantly over
the years to meet the needs for integrating and interpreting
various types of high-throughput data, as well as for sup-
porting translational bioinformatics (1). We have recently
returned to metabolism with a new attempt, which is a
synthesis of biological knowledge toward understanding
basic principles of metabolic networks (2). The concept
of data, information, knowledge and principle is now
used to improve the architecture and content of the
KEGG database. We expect that this will eventually
lead to logic-driven bioinformatics and first principle-
based computations.
LINKING GENOMES TO PHENOTYPES
Overview of KEGG
KEGG is an integrated database resource consisting of
15 main databases maintained in the internal Oracle
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database. As shown in Table 1 they are categorized
into systems information (PATHWAY, BRITE and
MODULE), genomic information (ORTHOLOGY,
GENOME and GENES), chemical information
(COMPOUND, GLYCAN, REACTION, RPAIR,
RCLASS and ENZYME) and health information
(DISEASE, DRUG and ENVIRON). The chemical and
health information categories are collectively called
KEGG LIGAND and KEGG MEDICUS, respectively.
KEGG MEDICUS contains two outside databases for
drug labels (package inserts) of all drugs marketed in
Japan and the USA, which are maintained as part of the
KEGG Oracle database. There are additional databases
not listed in Table 1, which are computationally generated
and maintained outside of the KEGG Oracle database.
They include the sequence similarity database SSDB for
genome annotation and auxiliary gene catalog databases
DGENES, MGENES and VGENES for draft genomes,
metagenomes and viral genomes, respectively.
Reference knowledge base
The original concept of KEGG was to create a reference
knowledge base of metabolism and other cellular
processes, so that it can be used for inferring higher-
level functions from genome sequence data. This concept
is unchanged after significant expansion of the knowledge
base, now containing organismal systems, human diseases
and drugs and the variety of data, now including
metagenomes, transcriptomes, metabolomes and other
high-throughput data. The reference knowledge base
consists of KEGG PATHWAY, BRITE and MODULE
databases (systems information category in Table 1).
During the past 2 years we implemented improvements
of the KEGG MODULE and PATHWAY databases to
automate interpretation of phenotypic features, especially
metabolic capacities, from genome and metagenome
sequences.
Genes to K numbers
The KEGG pathway maps, BRITE functional hierarchies
and KEGG modules are represented in a generic way to
be applicable to all organisms using the KEGG Orthology
(KO) system. For example, when a pathway map is drawn
based on experimental evidence in specific organisms, add-
itional work is performed for generalizing genes and
proteins in those specific organisms to other organisms
by converting to KO entries (ortholog groups), and if
necessary by creating new KO entries (Figure 1). Each
KO entry (identified by K number) is defined as a
sequence similarity group, although the degree of similar-
ity is context (pathway) dependent. This allows manually
created reference pathways to be computationally
expanded to organism-specific pathways, once genes in
the genome are annotated with K numbers based on
sequence similarity.
The genome annotation in KEGG is highly
computerized as illustrated in Figure 1. SSDB is a huge
graph of genes, whose edges are weighted by sequence
similarity scores and directed by best-hit relations. It is
continuously updated from the KEGG GENES
database by pairwise genome comparisons using the
SSEARCH program. The sequence similarity group of
each KO entry corresponds to a clique-like subgraph in
the SSDB graph, and the genome annotation involves
extending and modifying this subgraph. This is accom-
plished by the KOALA (KEGG Orthology And Links
Annotation) program, which evaluates sequence similarity
scores, best-hit relations, protein domains and taxonomy
groups for each gene in each genome using the GFIT
(Gene Function Identification Tool) table created from
SSDB. KOALA’s computational assignments (currently
performed three times a week) for a clean (clearly
defined) set of K numbers (currently 73%) are used to
automatically annotate genes in a newly determined
genome and also in the existing genomes that meet
Table 1. The KEGG resource including drug labels
Category Category name Database name Content
Systems Information KEGG PATHWAY KEGG pathway maps
KEGG BRITE BRITE functional hierarchies
KEGG MODULE KEGG modules
Genomic Information KEGG ORTHOLOGY KEGG Orthology (KO) groups
KEGG GENOME KEGG organisms with complete genomes
KEGG GENES Gene catalogs in complete genomes
Chemical Information KEGG LIGAND KEGG COMPOUND Metabolites and other small molecules
KEGG GLYCAN Glycans
KEGG REACTION Biochemical reactions
KEGG RPAIR Reactant pairs
KEGG RCLASS Reaction class
KEGG ENZYME Enzyme nomenclature
Health Information KEGG MEDICUS KEGG DISEASE Human diseases
KEGG DRUG Drugs
KEGG ENVIRON Crude drugs and health-related substances
JAPICa Drug labels in Japan
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certain criteria. Discrepancies between KOALA’s assign-
ments and current annotations are examined by annota-
tors with the manual version of KOALA and GFIT tools
(read-only copies are made available from KO and
GENES web pages), which are linked to additional tools
including gene cluster, ortholog table and phylogenetic
analysis tools. The manual tools are also extensively
used for grouping and regrouping of KO entries to
increase the clean set of K numbers (Figure 1).
K numbers to M numbers
The KEGG pathway map is drawn to present an overall
picture of the molecular interaction and reaction network,
often combining experimental evidence from multiple or-
ganisms. In contrast, the KEGG module (http://www.
kegg.jp/kegg/module.html) is a tighter functional unit of
molecules that generally corresponds to a conserved
subpathway in the KEGG pathway map. Each KEGG
module (identified by M number) is manually defined as
a combination of K numbers by examining gene conser-
vation patterns among organism groups and positional
correlations of genes (operon-like structures). The defin-
ition is described by a simple Boolean expression of K
numbers allowing computerized evaluation of whether
the gene set is complete, i.e. the functional unit is
present, based on the annotation (K number assignment)
of genes in the genome. For example, M00010, which
is named ‘Citrate cycle, first carbon oxidation,
oxaloacetate => 2-oxoglutarate’ and one of the most
conserved modules, is defined as:
M00010 ¼ K01647 ðK01681,K01682Þ ðK00031,K00030Þ
where a comma sign represents OR and a space or a plus
sign (for a molecular complex) represents AND when
evaluating this expression. The computerized evaluation,
which is implemented in both the internal annotation pro-
cedure and the KEGG module web page, also allows
detecting incomplete but almost complete modules. In
many cases these modules can become complete after a
few more genes are correctly annotated, but in some
cases they remain incomplete due to pseudogenes, frag-
mented genes and apparently missing genes in the
genome, which may indicate alternative genes and
pathways that are still unknown.
M numbers to phenotypes
The KEGG module collection is being expanded to allow
hierarchical definition of M numbers, where M numbers
are part of the Boolean expression to define another M
number. This will be used mostly in what we call signature
modules to describe phenotypes. For example, the
modules for methanogenesis M00567, M00357, M00356
and M00563 are separately defined by different K
number sets representing different reaction pathways.
Then, the phenotypic feature of methanogen M00617 is
defined as a combination:
M00617 ¼ M00567,M00357,M00356,M00563
The genome based annotation of phenotypes, mostly
metabolic capacities, is being added to the Keyword field
of the Genome entry page. Experimental evidence taken
from literature is added to its Comment field as part of the
metadata annotation of complete genomes. Now that the
number of KEGG organisms (complete genomes) is
reaching 3000, new tools will be developed to examine
relationships between organism groups and metabolic
capacities by using the organism level annotation of sig-
nature modules.
Reaction modules
The KEGG modules are defined by K numbers meaning
that they represent features of genes and genomes. In
contrast, the reaction modules that have been introduced
recently for metabolic pathways are defined by RC
(Reaction Class) numbers describing conserved sequences
of chemical structure transformation patterns of small
molecules. Figure 2 shows how reaction data are pro-
cessed in KEGG. The reaction class is like an ortholog
group of reactions representing functionally important
local structural changes and accommodating global struc-
tural differences. The reaction modules are extracted from
purely chemical properties without using any information
about enzymes and enzyme genes (3). Nevertheless,
reaction modules tend to correspond to KEGG modules.
For example, the KEGG module M00010 from
oxaloacetate (four-carbon or C4) to 2-oxoglutarate (C5)
matches the reaction module RM001 for ‘2-Oxocarboxylic
acid chain extension by tricarboxylic acid pathway’.
Furthermore, as illustrated in Figure 3, RM001 is found
in other pathways in combination with other reaction
modules for synthesizing basic amino acids, branched-
chain amino acids, coenzyme B and glucosinolates.
There are four different KEGG modules currently
defined for the same reaction module RM001, and the
constituent genes for the corresponding reaction steps
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Figure 1. A schematic diagram of genome annotation in KEGG. It
consists of two parts: defining KO entries represented by K numbers
(right) and assigning K numbers to genes in complete genomes (left).
The KO definition is manually done, but the K number assignment is
highly computerized (see text).
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modules have thus been used to improve the K number
grouping and associated annotations.
The reaction modules contain interesting features,
possibly design principles of a series of organic reactions
(2,3), including how to achieve an activated transition
state (e.g. phosphorylation), how to introduce a protective
group (e.g. N-acetylation), how to increase specificity (e.g.
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Figure 2. Reaction data processing in KEGG. The reaction formula is decomposed into a set of reactant pairs, one-to-one relationships of sub-
strate–product pairs. Each reactant pair is characterized by the local structure transformation pattern, called RDM pattern of KEGG atom type
changes. Among the reactant pairs that appear in the KEGG pathway maps, distinct RDM patterns are used to define reaction class entries
identified by RC numbers. The reaction module is a conserved sequence of RC numbers observed in different pathways. This example shows the
RDM pattern (R for reaction center atoms in red, D for difference region atoms in green and M for matched region atoms in blue) of RC00067,




















































































Figure 3. An example of the modular architecture of the metabolic network. The reaction module RM001 for chain extension of 2-oxocarboxylic
acids (large circles with the number of carbons) is used in combination with other reaction modules to generate amino acids (red circles),
glucosinolates (green circles) and coenzyme B (blue circle) (see details in http://www.kegg.jp/pathway/map01210).
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switching a carbon source from acetyl-CoA to malonyl-
CoA). An example is found in the two pathways for fatty
acid biosynthesis: the minor pathway in mitochondria
(RM020) utilizing acetyl-CoA as a carbon source, which
is a reversal of beta-oxidation (RM018), and the major
pathway (RM021) utilizing acyl carrier protein and
malonyl-CoA as a carbon source. RM021 appears to be
more advanced than RM020 in the possible evolution of
reaction modules.
Metabolism overview maps
The pathway maps similar to Figure 3 are now made
available under the category of metabolism overview
maps (map numbers 01200s). In contrast to the previously
developed global maps (map numbers 01100s), which
omit intermediate reaction steps, the overview maps
contain all the reaction steps as in the regular KEGG
metabolic pathway maps. In addition, they are manually
annotated with KEGG modules and reaction modules.
These maps represent our efforts to present design prin-
ciples of the metabolic network rather than traditional
views of individual pathways. The modular architecture
of the metabolic network is apparent in 2-oxocarboxylic
acid metabolism (map01210), fatty acid metabolism
(map01212) and degradation of aromatic compounds
(map01220), but the central carbon metabolism
(map01200) seems to contain a different design principle.
It is an extensive use of the same paths with minor modi-
fications (2), such as reductive pentose phosphate pathway
that contains two key reaction steps catalyzed by
RuBisCO and PRK. The overview maps, together with
KEGG modules and reaction modules, will be expanded
toward understanding basic principles of metabolic
networks.
Note that for these new overview maps, the EC number
reference pathways (map numbers prefixed with ec) are no
longer supported. The EC numbers are given to biochem-
ically well-characterized enzymes and enzymatic reactions
in Enzyme Nomenclature (4), but there are many reactions
that do not qualify for EC numbers, such as those
identified by genetic experiments or inferred from meta-
bolic pathways. Less than one half of the reactions in the
KEGG REACTION database are associated with EC
numbers, and this ratio becomes smaller for those reac-
tions that appear in the KEGG pathway maps (3). There
are also many EC numbers whose sequence information is
unknown (5). Since the EC numbers are given as attributes
of KO entries (K numbers) and reaction entries (R
numbers), their use as identifiers are highly discouraged
in KEGG Mapper and other applications.
LINKING GENOMES TO SOCIETY
KEGG MEDICUS
KEGG MEDICUS is an integrated information resource
of diseases, drugs and health-related substances, aiming to
bring the genomic revolution to society. Specifically, the
drug labels (package inserts) are now part of KEGG
MEDICUS (Table 1). The Japanese drug labels are fully
integrated in the KEGG Oracle database using the XML
data provided monthly from the Japan Pharmaceutical
Information Center (JAPIC). For the drug labels in the
USA only the information taken from the FDA’s
National Drug Code (NDC) database is in Oracle, and
the actual contents are referred to the DailyMed
website. The KEGG DRUG database was originally de-
veloped as a unified resource for drugs in Japan, the USA
and Europe, where active ingredients and their mixtures
are distinguished by chemical structures and/or chemical
components and represented by KEGG DRUG entries
(identified by D numbers). The D numbers have been
linked, for example, to targets in the KEGG pathway
maps and drug ontologies in the BRITE hierarchies.
Now that the drug labels data in Japan and the USA
are linked to D numbers, both scientific data used in the
scientific community and practical data used in society are
integrated through the KEGG DRUG database. Figure 4
illustrates a drug hierarchy showing that slightly different
chemical structures (D numbers) of warfarin are linked to
WHO’s Anatomical Therapeutic Chemical (ATC) classifi-
cation, and also to drug labels and drug products in the
USA and Japan (not shown).
Drug interaction database
The full text information of the entire set of Japanese drug
labels is a great source for developing scientific databases.
In particular, a drug interaction database has been de-
veloped (6). Adverse drug interactions associated with
contraindications and precautions are listed in a tabular
form in the Japanese drug labels. Drug names and drug
group names are extracted and converted to D numbers
and D number groups using internally developed
dictionaries for standardizing variations and synonyms.
The resulting D number pairs are annotated with
possible causes, such as CYP enzyme or drug target in-
volvement, using the information stored in the KEGG
B  BLOOD AND BLOOD FORMING ORGANS 
 B01  ANTITHROMBOTIC AGENTS 
B01A  ANTITHROMBOTIC AGENTS 
B01AA  Vitamin K antagonists 
B01AA01  Dicoumarol 
B01AA02  Phenindione 
B01AA03  Warfarin 
D08682  Warfarin 
D00564  Warfarin sodium (USP) 
d91934a0-902e-c26c-23ca-d5accc4151b6  Coumadin 
0056-0169  COUMADIN tablet 1 mg 
0056-0170  COUMADIN tablet 2 mg 
0056-0176  COUMADIN tablet 2.5 mg 
0056-0188  COUMADIN tablet 3 mg 
0056-0168  COUMADIN tablet 4 mg 
0056-0172  COUMADIN tablet 5 mg 
0056-0189  COUMADIN tablet 6 mg 
0056-0173  COUMADIN tablet 7.5 mg 
0056-0174  COUMADIN tablet 10 mg 
............ 
D01280  Warfarin potassium (JP16) 
(Japanese warfarin is under this category)
Figure 4. The KEGG DRUG D numbers play a role of integrating
different types of data and information, now including drug labels and
drug products. Here, D numbers are used to integrate the ATC classi-
fication and drug products, effectively classifying all drug products in
the USA (see http://www.kegg.jp/brite/br08303_ndc).
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DRUG database. Drug interactions can be searched for a
given set of D numbers at the KEGG DRUG web page
and also through the drug–drug interaction (DDI) search
button in each KEGG DRUG entry. In the Japanese
version of KEGG MEDICUS, drug interactions can be
searched at the product level, giving more detailed infor-
mation extracted from the drug labels.
Chemical ingredients of drugs include not only active
ingredients but also different types of pharmaceutical
additives, which may also cause adverse effects. All
additives in each drug product are extracted from the
Japanese drug labels and converted to KEGG DRUG D
numbers, KEGG COMPOUND C numbers and KEGG
ENVIRON E numbers. The search interface is available
for Japanese drug products in the Japanese version of
KEGG MEDICUS.
Translational bioinformatics
Translational bioinformatics usually means bioinfor-
matics resources and technologies that help bring
research results into practical applications. Here it also
means bioinformatics resources directly targeted to
society that help to understand the scientific basis of
diseases and drugs of personal interest. The latter aspect
of translational bioinformatics is successfully implemented
in the Japanese version of KEGG MEDICUS, which has
a big impact on the web access statistics. The number of
visitors (unique IP addresses) per month increased from
200 000 to 500 000 in the past 2 years, and many of them
now come directly from web search engines. The drug in-
formation is universal at the level of D numbers represent-
ing active ingredients, but actual drug products vary in
different countries. We will be unable to directly provide
a service of the same quality as in Japan, but the KEGG
MEDICUS resource can be used to develop a similar
service in many countries. The Japanese and US drug
labels currently maintained in KEGG are like KEGG
organisms for genome analysis. As shown in Table 2
new genome sequences and other user-defined data can
be integrated with KEGG, once the IDs are properly
converted to KEGG IDs. Similarly, once drug labels
in any country are linked to the KEGG DRUG D
number identifiers, the whole array of KEGG resources
including the drug interaction database, drug targets,
drug metabolism and drug classifications become
available.
Accessing KEGG
KEGG is made available at both the KEGG website
(http://www.kegg.jp/) and the GenomeNet website
(http://www.genome.jp/kegg/). The internal KEGG
Oracle database is copied daily to a public version as a
read-only PostgreSQL database, which is available only at
the KEGG website. LinkDB and various analysis tools
including KAAS and SIMCOMP are available only at
the GenomeNet website. However, these differences may
not be noticeable by the users because mutual links are
made as if they are a single site.
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